Skip to main navigation Skip to main content Skip to page footer

Infezioni da Herpes virus

Informazioni cliniche

La famiglia degli herpesvirus comprende più di 100 tipi di virus diversi, otto dei quali possono causare infezioni nell'uomo. Questi cosiddetti herpesvirus umani comprendono il virus Herpes simplex di tipo 1 e 2 (HSV-1 e -2), il virus varicella-zoster (VZV), il virus Epstein-Barr (EBV), il Citomegalovirus (CMV), gli herpesvirus umani 6 e 7 (HHV-6 e -7) e l'herpesvirus umano 8 (HHV-8), associato al sarcoma di Kaposi. Nonostante le grandi somiglianze strutturali tra i diversi patogeni, l'infezione da herpesvirus può causare malattie molto diverse tra loro, ad esempio l'herpes labiale o genitale, la varicella, il fuoco di Sant‘Antonio, la malattia del bacio o diversi tipi di cancro. Durante la gravidanza, soprattutto l'infezione primaria con particolari herpesvirus può portare a gravi lesioni o addirittura alla perdita del bambino. Attualmente esiste solo un vaccino contro il VZV. Dopo l'infezione primaria, che spesso procede in modo asintomatico, gli herpesvirus persistono per tutta la vita nell'organismo in uno stato latente e possono riattivarsi in un momento successivo, ad esempio a causa di un sistema immunitario indebolito, e causare (di nuovo) sintomi.

Diagnostica

La diagnostica di laboratorio degli herpesvirus si basa su metodi di rilevamento diretti o indiretti. I metodi diretti, che sono particolarmente importanti per la diagnosi di infezioni acute o in persone immunodepresse, includono, ad esempio, la coltura del virus o i test basati sulla PCR, in cui vengono rilevati gli acidi nucleici virali. Come materiale di campionamento si utilizzano: liquido vescicolare, strisci di pelle o di mucosa, sangue, liquor o liquido di lavaggio broncoalveolare. Se l'anticorpo specifico per l'herpesvirus viene rilevato nel siero, nel plasma o nel liquor del paziente, questo viene considerato un rilevamento indiretto del patogeno. La rilevazione degli anticorpi non solo consente di trarre conclusioni su quale virus sia presente nel paziente, ma può anche contribuire alla differenziazione di infezioni primarie e ricorrenti. EUROIMMUN offre un'ampia gamma di prodotti per la rilevazione delle infezioni da herpesvirus, che comprendono sia la rilevazione degli anticorpi che i metodi di rilevazione diretta.

Methods
Technology Parameter Substrate Species Calibration Ig Class Format Order No.
ELISA CSQ pair of controls
anti-Cytomegalovirus (IgG)
IgG 02 x 20
CK 2570-0220-L G
ELISA CSQ pair of controls
anti-EBV-CA (IgG)
IgG 02 x 20
CK 2791-0220-L G
ELISA CSF: Anti-CMV ELISA (IgG)
cytomegalovirus
Sample type: CSF/serum pair
antigen-coated
microplate wells
native antigens
from CMV
5/25/50/100 U IgG 96 x 01
EI 2570-9601-L G
ELISA CSF: Anti-EBV-CA-ELISA (IgG)
Epstein-Barr virus capsid antigen
Sample type: CSF/serum pair
antigen-coated
microplate wells
native, mixture of several
viral capsid antigens
5/25/50/100 U IgG 96 x 01
EI 2791-9601-L G
ELISA CSQ pair of controls
anti-HSV-1/2 Pool (IgG)
IgG 02 x 20
CK 2531-0220-1 L G
ELISA CSF: Anti-HSV-1/2 Pool ELISA (IgG)
herpes simplex virus
Sample type: CSF/serum pair
antigen-coated
microplate wells
native antigens
from HSV-1 and HSV-2
5/25/50/100/175/230 U/ml IgG 96 x 01
EI 2531-9601-1 L G
ELISA CSQ pair of controls
anti-VZV (IgG)
IgG 02 x 20
CK 2650-0220-L G
IIFT HHV-6 infected cells EU 30 IgG
IgM
IgG
IgM
IgG
IgM
IgG
IgM
10 x 05
10 x 05
10 x 10
10 x 10
20 x 05
20 x 05
20 x 10
20 x 10
FI 2536-1005 G
FI 2536-1005 M
FI 2536-1010 G
FI 2536-1010 M
FI 2536-2005 G
FI 2536-2005 M
FI 2536-2010 G
FI 2536-2010 M
IIFT Epstein-Barr
virus capsid antigen
(EBV-CA)
expressing cells P3HR1 IgG EB
IgM EB
IgG EB
IgM EB
IgM EB
IgG EB
10 x 05
10 x 05
10 x 10
10 x 10
20 x 05
20 x 10
FI 2791-1005 G
FI 2791-1005 M
FI 2791-1010 G
FI 2791-1010 M
FI 2791-2005 M
FI 2791-2010 G
IIFT Epstein-Barr virus
nuclear antigen (EBNA,
complement-fixing antibodies)
expressing cells Raji C3c EB 10 x 10
FI 2793-1010 C
IIFT Epstein-Barr
virus early antigen
(EBV-EA)
expressing cells EU 33 IgG EB
IgG EB
10 x 05
10 x 10
FI 2795-1005 G
FI 2795-1010 G
IIFT BIOCHIP
Sequence EBV
fields A and B: EBV-CA (IgG)
field C: EBV-CA (IgM)
field D: EBV-EA
field E: EBNA


expressing cells
expressing cells
expressing cells
expressing cells


P3HR1
P3HR1
EU 33
Raji
Aviditätsbestimmung
Aviditätsbestimmung
Aviditätsbestimmung
Aviditätsbestimmung
10 x 01
10 x 02
20 x 01
20 x 02
FI 2799-1001-1 X
FI 2799-1002-1 X
FI 2799-2001-1 X
FI 2799-2002-1 X
IIFT EUROPLUS
BIOCHIP Sequence EBV
field A: EBV-CA (IgG), gp125 ag, p19 ag

field B: EBV-CA (IgG)
field C: EBV-CA (IgM), gp125 ag, p19 ag

field D: EBV-EA
field E: EBNA


expr. cells, gp125/p19/
ag-free BIOCHIP
expressing cells
expressing cells
expr. cells, gp125/p19/
ag-free BIOCHIP
expressing cells


P3HR1, native/rec.
EU 120
P3HR1
P3HR1, native/rec.
EU 120
EU 33
Raji
Aviditätsbestimmung
Aviditätsbestimmung
Aviditätsbestimmung
Aviditätsbestimmung
10 x 01
10 x 02
20 x 01
20 x 02
FI 2799-1001-21 X
FI 2799-1002-21 X
FI 2799-2001-21 X
FI 2799-2002-21 X
IIFT HHV-6 EUROPattern infected cells EU 30 IgG EB
IgM EB
IgG EB
IgM EB
IgG EB
IgM EB
IgG EB
IgM EB
10 x 05
10 x 05
10 x 10
10 x 10
20 x 05
20 x 05
20 x 10
20 x 10
FR 2536-1005 G
FR 2536-1005 M
FR 2536-1010 G
FR 2536-1010 M
FR 2536-2005 G
FR 2536-2005 M
FR 2536-2010 G
FR 2536-2010 M
ELISA Anti-EBV-CA ELISA (IgA)
Epstein-Barr virus capsid antigen
antigen-coated
microplate wells
native, mixture of several
viral capsid antigens
semi-quantitative IgA 96 x 01
EI 2791-9601 A
ELISA Anti-EBV-CA ELISA (IgG)
Epstein-Barr virus capsid antigen
antigen-coated
microplate wells
native, mixture of several
viral capsid antigens
2/20/200 RU/ml IgG 96 x 01
EI 2791-9601 G
ELISA Anti-EBV-CA ELISA (IgM)
Epstein-Barr virus capsid antigen
antigen-coated
microplate wells
native gp125
of EBV
semi-quantitative IgM 96 x 01
EI 2791-9601 M
ELISA Avidity: Anti-EBV-CA-ELISA (IgG)
Epstein-Barr virus capsid antigen
avidity determination
antigen-coated
microplate wells
native, mixture of several
viral capsid antigens
2/20/200 RU/ml IgG 96 x 01
EI 2791-9601-1 G
ELISA Anti-EBNA-1 ELISA (IgG)
Epstein-Barr virus nuclear antigen
antigen-coated
microplate wells
recombinant
EBNA-1 from EBV
2/20/200 RU/ml IgG 96 x 01
EI 2793-9601 G
ELISA Anti-EBV-EA-D ELISA (IgA)
Epstein-Barr virus early antigen
antigen-coated
microplate wells
recombinant early antigen D
from EBV
semi-quantitative IgA 96 x 01
EI 2795-9601 A
ELISA Anti-EBV-EA-D ELISA (IgG)
Epstein-Barr virus early antigen
antigen-coated
microplate wells
recombinant early antigen D
from EBV
2/20/200 RU/ml IgG 96 x 01
EI 2795-9601 G
ELISA Anti-EBV-EA-D ELISA (IgM)
Epstein-Barr virus early antigen
antigen-coated
microplate wells
recombinant early antigen D
from EBV
semi-quantitative IgM 96 x 01
EI 2795-9601 M
EUROLINE positive control serum: IgG, human, 50x concentrated
for EBV-Profil 2 G
IgG 05 x 07
CL 2790-0507-12 G
EUROLINE positive control serum: IgM, human, 50x concentrated
for EBV-Profil 2 M
IgM 05 x 07
CL 2790-0507-12 M
EUROLINE EUROLINE Anti-EBV Profile 2 (IgM)
(VCA gp125, VCA p19,
EBNA-1, p22, EA-D separately)
EUROLINE IgM
IgM
IgM
05 x 10
16 x 01
64 x 01
DN 2790-0510-2 M
DN 2790-1601-2 M
DN 2790-6401-2 M
EUROLINE EUROLINE Anti-EBV (IgM)
(VCA gp125, VCA p19, EA-D separately)
EUROLINE IgM
IgM
IgM
05 x 10
16 x 01
64 x 01
DN 2790-0510-4 M
DN 2790-1601-4 M
DN 2790-6401-4 M
EUROLINE EUROLINE Anti-EBV Profile 2 (IgG)
(VCA gp125, VCA p19,
EBNA-1, p22, EA-D separately)
EUROLINE IgG
IgG
IgG
16 x 01
50 x 01
64 x 01
DN 2790-1601-2 G
DN 2790-5001-2 G
DN 2790-6401-2 G
EUROLINE EUROLINE Anti-EBV (IgG)
(VCA gp125, VCA p19, EBNA-1, p22. EA-D separately)
EUROLINE IgG
IgG
IgG
16 x 01
50 x 01
64 x 01
DN 2790-1601-4 G
DN 2790-5001-4 G
DN 2790-6401-4 G
ChLIA IDS EBV VCA IgG antigenic coated magnetic particles Capsid antigen quantitative
100 x 01
IS-ID58011
ChLIA IDS EBV VCA IgM antigenic coated magnetic particles Capsid antigen quantitative
100 x 01
IS-ID58021
ChLIA IDS EBV EBNA-1 IgG antigenic coated magnetic particles EBNA-1 quantitative
100 x 01
IS-ID58031
ChLIA IDS EBV EA IgG antigenic coated magnetic particles EA-D antigen quantitative
50 x 01
IS-ID58041
ChLIA IDS EBV Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-ID58301
ChLIA Anti-EBV-CA ChLIA (IgG)
Epstein-Barr virus capsid antigen
Antigen-coated magnetic particles recombinant
p18, p23, gp125
quantitative IgG 100 x 1
LI 2791-10010 G
ChLIA Anti-EBV-CA ChLIA (IgM)
Epstein-Barr virus capsid antigen
Antigen-coated magnetic particles recombinant
p18, gp125
quantitative IgM 100 x 1
LI 2791-10010 M
ChLIA Anti-EBNA-1 ChLIA (IgG)
Epstein-Barr virus nuclear antigen
Antigen-coated magnetic particles recombinant
EBNA-1
quantitative IgG 100 x 1
LI 2793-10010 G
ChLIA Control set Anti-EBV-CA ChLIA (IgG)
Epstein-Barr virus capsid antigen
2 x 0.5 ml control 1/2 IgG 02 x 02
LR 2791-20210 G
ChLIA Control set Anti-EBV-CA ChLIA (IgM)
Epstein-Barr virus capsid antigen
2 x 0.5 ml control 1/2 IgM 02 x 02
LR 2791-20210 M
ChLIA Control set Anti-EBNA-1 ChLIA (IgG)
Epstein-Barr virus nuclear antigen
2 x 0.5 ml control 1/2 IgG 02 x 02
LR 2793-20210 G
MICROBLOT EUROMicroblot Anti-EBV (IgG) IgG 96 x 01
KN 2790-9601 G
MICROBLOT EUROMicroblot Anti-EBV (IgM) IgM 96 x 01
KN 2790-9601 M
ELISA Anti-CMV ELISA (IgG)
cytomegalovirus
antigen-coated
microplate wells
native antigens
from CMV
2/20/200 RU/ml IgG 96 x 01
EI 2570-9601 G
ELISA Anti-CMV ELISA (IgM)
cytomegalovirus
antigen-coated
microplate wells
native antigens
from CMV
semi-quantitative IgM 96 x 01
EI 2570-9601 M
ELISA Avidity: Anti-CMV ELISA (IgG)
cytomegalovirus
avidity determination
antigen-coated
microplate wells
native antigens
from CMV
2/20/200 RU/ml IgG 96 x 01
EI 2570-9601-1 G
ELISA Anti-CMV p52 ELISA (IgM)
cytomegalovirus
p52 antigen from CMV
antigen-coated
microplate wells
native antigens
from CMV
semi-quantitative IgM 96 x 01
EI 2570-9601-2 M
ELISA Anti-CMV gB ELISA (IgG)
cytomegalovirus glycoprotein B
glycoprotein B antigen from CMV
antigen-coated
microplate wells
recombinant
glycoprotein B antigen from CMV
2/20/200 RU/ml IgG 96 x 01
EI 2570-9601-3 G
EUROLINE positive control serum: IgG, human, 50x concentrated
for CMV
IgG 05 x 07
CL 2570-0507 G
EUROLINE positive control serum: IgM, human, 50x concentrated
for CMV
IgM 05 x 07
CL 2570-0507 M
EUROLINE EUROLINE Anti-CMV (IgG) EUROLINE IgG
IgG
IgG
16 x 01
50 x 01
64 x 01
DN 2570-1601-2 G
DN 2570-5001-2 G
DN 2570-6401-2 G
EUROLINE EUROLINE Anti-CMV (IgM) EUROLINE IgM
IgM
IgM
16 x 01
50 x 01
64 x 01
DN 2570-1601-2 M
DN 2570-5001-2 M
DN 2570-6401-2 M
ChLIA IDS CMV IgG antigenic coated magnetic particles CMV antigen qualitative
100 x 01
IS-ID54011
ChLIA IDS CMV IgM antigenic coated magnetic particles CMV antigen qualitative
100 x 01
IS-ID54021
ChLIA IDS CMV Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-ID54301
ChLIA IDS CMV IgG Avidity antigenic coated magnetic particles CMV antigen qualitative
50 x 01
IS-ID55011
ChLIA IDS CMV Avidity Control Set 3 x 1.0 ml Control 1/2 human serum 2 concentrations
IS-ID55301
ELISA Anti-HSV-1/2 Pool ELISA (IgG)
herpes simplex virus
native antigens from HSV-1 and HSV-2
antigen-coated
microplate wells
native antigens
from HSV-1 and HSV-2
2/20/200 RU/ml IgG 96 x 01
EI 2531-9601-1 G
ELISA Anti-HSV-1/2 Pool ELISA (IgM)
herpes simplex virus
native antigens from HSV-1 and HSV-2
antigen-coated
microplate wells
native antigens
from HSV-1 and HSV-2
semi-quantitative IgM 96 x 01
EI 2531-9601-1 M
ELISA Anti-HSV-1 (gC1) ELISA (IgG)
herpes simplex virus 1
recombinant glycoprotein C1 from HSV-1
antigen-coated
microplate wells
recombinant
glycoprotein C1
2/20/200 RU/ml IgG 96 x 01
EI 2531-9601-2 G
ELISA Anti-HSV-2 (gG2) ELISA (IgG)
herpes simplex virus 2
recombinant glycoprotein G2 from HSV-2
antigen-coated
microplate wells
recombinant
glycoprotein G2
2/20/200 RU/ml IgG 96 x 01
EI 2532-9601-2 G
WESTERNBLOT antibodies against Herpes simplex virus (HSV)
IgG positive control
IgG 50 x 05
CW 2531-5005 G
WESTERNBLOT Anti-HSV-1 / HSV-2 gG-2 EUROLINE-WB (IgG)
Herpes simplex virus 1 (HSV-1) plus HSV-2 type-specific glycoprotein G2
Westernblot whole antigen, SDS extract of HSV-1
plus purified gG2
IgG 16 x 01
DY 2531-1601-1 G
WESTERNBLOT Anti-HSV-1 / HSV-2 gG-2 EUROLINE-WB (IgM)
Herpes simplex virus 1 (HSV-1) plus HSV-2 type-specific glycoprotein G2
Westernblot whole antigen, SDS extract of HSV-1
plus purified gG2
IgM 16 x 01
DY 2531-1601-1 M
ChLIA IDS HSV-1 IgG antigenic coated magnetic particles gG1 antigen quantitative
100 x 01
IS-ID56011
ChLIA IDS HSV-2 IgG antigenic coated magnetic particles gG2 antigen quantitative
100 x 01
IS-ID56021
ChLIA IDS HSV 1/2 IgG Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-ID56301
ChLIA IDS HSV 1/2 IgM antigenic coated magnetic particles gG1 and gG2 antigens quantitative
100 x 01
IS-ID57011
ChLIA IDS HSV 1/2 IgM Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-ID57301
ChLIA Anti-Herpes simplex virus 1 ChLIA (IgG) Antigen-coated magnetic particles recombinant gG1 quantitative IgG 100 x 1
LI 2531-10010 G
ChLIA Anti-Herpes simplex virus 2 ChLIA (IgG) Antigen-coated magnetic particles rekombinant gG2 quantitative IgG 100 x 1
LI 2532-10010 G
ChLIA Control set Anti-HSV 1 ChLIA (IgG) 2 x 0.5 ml control 1/2 IgG 02 x 02
LR 2531-20210 G
ChLIA Control set Anti-HSV 2 ChLIA (IgG) 2 x 0.5 ml control 1/2 IgG 02 x 02
LR 2532-20210 G
IIFT Varicella zoster virus
(VZV)
infected cells EU 168 IgG
IgM
IgG
IgM
10 x 05
10 x 05
10 x 10
10 x 10
FI 2650-1005 G
FI 2650-1005 M
FI 2650-1010 G
FI 2650-1010 M
ELISA Anti-VZV ELISA (IgA)
Varicella zoster virus
antigen-coated
microplate wells
native antigens
from VZV
semi-quantitative IgA 96 x 01
EI 2650-9601 A
ELISA Anti-VZV ELISA (IgG)
Varicella zoster virus
antigen-coated
microplate wells
native antigens
from VZV
10/100/500/5000 IU/l IgG 96 x 01
EI 2650-9601 G
ELISA Anti-VZV ELISA (IgM)
Varicella zoster virus
antigen-coated
microplate wells
native antigens
from VZV
semi-quantitative IgM 96 x 01
EI 2650-9601 M
ELISA Avidity: Anti-VZV ELISA (IgG)
Varicella zoster virus
avidity determination
antigen-coated
microplate wells
native antigens
from VZV
10/100/500/5000 IU/l IgG 96 x 01
EI 2650-9601-1 G
ELISA Anti-VZV ELISA 2.0 (IgG)
Varicella zoster virus
antigen-coated
microplate wells
native antigens from VZV IgG 96 x 01
EI 2650-9601-2 G
ELISA Anti-VZV Glycoprotein ELISA (IgM)
Varicella zoster virus
antigen-coated
microplate wells
native glycoproteins
from VZV
semi-quantitative IgM 96 x 01
EI 2650-9601-2 M
ChLIA IDS VZV IgG antigenic coated magnetic particles VZV virus antigen quantitative
50 x 01
IS-ID59031
ChLIA IDS MMV IgG Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-ID59301
ChLIA IDS VZV IgM antigenic coated magnetic particles VZV virus antigen quantitative
50 x 01
IS-ID60031
ChLIA IDS MMV IgM Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-ID60301
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC.
1 Product manufactured by third party. Please contact your local Euroimmun representative for more information.